If rates of PSA (prostate-specific antigen) stay elevated or increase following cancer treatment such are indicators of recurrence of prostate cancer. A variety of reasons, including The strategy for managing prostate cancer recurrent cases vary.

• The type(s) the patient got from prior cancer therapy(s).

• The scale and position of the replication of cancer.

• The patient’s age and other medical issues.

Follow-up treatment is typically expected in patients diagnosed with conventional surgery, radiation, and chemotherapy. CyberKnife is used for the treatment and prevention of prostate cancer recurrences along with conventional cancer treatments, as well as immunotherapy and proton therapy by our urologist in Ludhiana.

How do prostate recurrence oncologists diagnose?

The level of PSA in the blood of a patient usually decreases and remains steady after a prostatic cancer diagnosis. Many people undergo daily medical examinations, including mandatory PSA exams, after diagnosis. It may be a symptom of a prostate cancer recurrence if PSA rates begin to increase.

Further testing will be required to decide if growing PSA rates indicate a recurrence or cancer spread to other areas of the body. Doctors may use bone scans, X-rays, or do an Axumin PET scan utilizing calcium-related radioactive agents to identify the whole body’s cancerous cells. Axumin can identify carcinogenic tissue in patients with PSA rates below 10, as compared to traditional screening approaches that allow rates of PSA from 10-50 for cancer detection.

Types of prostate cancer recurrence

The two main forms of CyberKnife-treated recurrence of prostate cancer are local and distant. The recurrence of the prostate tissue, such as the seminal vesicles, tissues of the pelvic floor, or rectum, is termed local recurrence. The cancer recurrence outside the pelvis is known as a remote or distant recurrence, for example where a tumor is formed in distant lymph nodes. The recurrents arise outside the pelvis.

Often, an individual can have higher PSA rates without any other strong sign of a cancer recurrence. In a patient’s MRI studies, for example, no apparent cancer will occur.

This could indicate successful clinical monitoring for patients with steadily increasing prostate cancers.

Prostate cancer recurrence chance

Several variables may suggest an elevated likelihood of recurrence of prostate cancer from a patient’s initial diagnosis. This involves the tumor scale, the cancer stage, and degree and how either of the lymph nodes has been damaged by the disease.

Recurrence is more common with patients diagnosed with advanced stages of prostate cancer and patients with higher Gleason scores (or prostate cancer levels). There is also a higher chance of recurrence in patients with broad tumors or lymph nodes damaged by prostate cancer.